1. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Issue 3 (March 2023) Authors: Laffel, Lori M; Danne, Thomas; Klingensmith, Georgeanna J; Tamborlane, William V; Willi, Steven; Zeitler, Philip; Neubacher, Dietmar; Marquard, Jan; Bardymova, Tatiana; Barrientos Perez, Margarita; Bethin, Kathleen; Bjornstad, Petter; Bondar, Irina; Chen, Mimi; Choi, Jin-Ho; Clements, Mark A; Col... Journal: Lancet Issue: Volume 11:Issue 3(2023) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial. Issue 9 (5th June 2018) Authors: Shimada, Akira; Hanafusa, Toshiaki; Yasui, Atsutaka; Lee, Ganghyuck; Taneda, Yusuke; Sarashina, Akiko; Shiki, Kosuke; George, Jyothis; Soleymanlou, Nima; Marquard, Jan Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 9(2018) Page Start: 2190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. Issue 7 (1st August 2017) Authors: Farsani, Soulmaz Fazeli; Brodovicz, Kimberly; Soleymanlou, Nima; Marquard, Jan; Wissinger, Erika; Maiese, Brett A Journal: BMJ open Issue: Volume 7:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Kidney Effects of Empagliflozin in People with Type 1 Diabetes. Issue 11 (November 2021) Authors: Cherney, David Z.I.; Bjornstad, Petter; Perkins, Bruce A.; Rosenstock, Julio; Neubacher, Dietmar; Marquard, Jan; Soleymanlou, Nima Journal: Clinical journal of the American Society of Nephrology Issue: Volume 16:Issue 11(2021) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Issue 1 (December 2015) Authors: Welters, Alena; Lerch, Christian; Kummer, Sebastian; Marquard, Jan; Salgin, Burak; Mayatepek, Ertan; Meissner, Thomas Journal: Orphanet journal of rare diseases Issue: Volume 9:Issue 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low‐dose empagliflozin as adjunct‐to‐insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy. Issue 3 (21st January 2020) Authors: Perkins, Bruce A.; Soleymanlou, Nima; Rosenstock, Julio; Skyler, Jay S.; Laffel, Lori M.; Liesenfeld, Karl‐Heinz; Neubacher, Dietmar; Riggs, Matthew M.; Johnston, Curtis K.; Eudy‐Byrne, Rena J.; Elmokadem, Ahmed; George, Jyothis T.; Marquard, Jan; Nock, Valerie Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop. Issue 1 (16th March 2020) Authors: Barrett, Jeffrey S.; Bucci‐Rechtweg, Christina; Amy Cheung, S. Y.; Gamalo‐Siebers, Margaret; Haertter, Sebastian; Karres, Janina; Marquard, Jan; Mulugeta, Yeruk; Ollivier, Cecile; Strougo, Ashley; Yanoff, Lisa; Yao, Lynne; Zeitler, Philip Journal: Clinical pharmacology & therapeutics Issue: Volume 108:Issue 1(2020) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Population Pharmacokinetic– Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus. (18th December 2017) Authors: Mondick, John; Riggs, Matthew; Kaspers, Stefan; Soleymanlou, Nima; Marquard, Jan; Nock, Valerie Journal: Journal of clinical pharmacology Issue: Volume 58:Number 5(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomized, double‐blind, placebo‐controlled dose‐finding study of the dipeptidyl peptidase‐4 inhibitor linagliptin in pediatric patients with type 2 diabetes. Issue 4 (24th November 2017) Authors: Tamborlane, William V; Laffel, Lori MB; Weill, Jacques; Gordat, Maud; Neubacher, Dietmar; Retlich, Silke; Hettema, Willem; Hoesl, Cornelia E; Kaspers, Stefan; Marquard, Jan Journal: Pediatric diabetes Issue: Volume 19:Issue 4(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗